05/23/2024 4:07 PM | Cullinan Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/16/2024 4:40 PM | Cullinan Therapeutics (Issuer) Meek David D. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/16/2024 4:30 PM | Cullinan Therapeutics (Issuer) Meek David D. (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
05/16/2024 6:30 AM | Cullinan Therapeutics (Filer)
| Form ARS | |
05/16/2024 5:42 AM | Cullinan Therapeutics (Filer)
| Form DEFA14A | |
05/16/2024 5:40 AM | Cullinan Therapeutics (Filer)
| Form DEF 14A | |
05/08/2024 6:30 PM | Cullinan Therapeutics (Issuer) Michaelson Jennifer (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
|
05/06/2024 3:32 PM | Cullinan Therapeutics (Subject) Michaelson Jennifer (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
04/30/2024 7:58 PM | Cullinan Therapeutics (Issuer) Fenton Mary Kay (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
04/30/2024 8:02 PM | Cullinan Therapeutics (Issuer) Fenton Mary Kay (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/29/2024 6:05 AM | Cullinan Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/24/2024 4:50 PM | Cullinan Therapeutics (Subject) Flynn James E (Filed by)
| Form SC 13G | |
04/16/2024 6:14 AM | Cullinan Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/02/2024 7:50 PM | Cullinan Therapeutics (Issuer) Nguyen Nate (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
03/14/2024 6:22 AM | Cullinan Therapeutics (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
03/14/2024 6:27 AM | Cullinan Therapeutics (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/14/2024 6:14 AM | Cullinan Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/23/2024 4:00 PM | Cullinan Therapeutics (Issuer) SUMER JACQUELYN L (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/23/2024 4:00 PM | Cullinan Therapeutics (Issuer) Trigilio Jeffrey (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/23/2024 4:00 PM | Cullinan Therapeutics (Issuer) Jones Jeffrey Alan (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/23/2024 4:00 PM | AHMED NADIM (Reporting) Cullinan Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/23/2024 4:00 PM | Cullinan Therapeutics (Issuer) Savill Corrine (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/14/2024 8:01 PM | Blue Owl Capital Holdings LP (Filed by) Cullinan Therapeutics (Subject)
| Form SC 13G | |
02/06/2024 9:09 AM | Cullinan Therapeutics (Subject) FRANKLIN RESOURCES INC (Filed by)
| Form SC 13G | |
02/02/2024 8:35 PM | Cullinan Therapeutics (Issuer) Savill Corrine (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/01/2024 3:43 PM | Cullinan Therapeutics (Subject) Savill Corrine (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/30/2024 6:00 PM | Cullinan Therapeutics (Issuer) Savill Corrine (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/29/2024 4:25 PM | BlackRock Inc. (Filed by) Cullinan Therapeutics (Subject)
| Form SC 13G | |
01/29/2024 3:27 PM | Cullinan Therapeutics (Subject) Savill Corrine (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/22/2024 3:18 PM | Cullinan Therapeutics (Subject) Savill Corrine (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/08/2024 3:15 PM | Cullinan Therapeutics (Filer)
| Form 8-K/A | |
01/08/2024 8:12 AM | Cullinan Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/27/2023 5:30 PM | AHMED NADIM (Reporting) Cullinan Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/22/2023 4:30 PM | Cullinan Therapeutics (Issuer) Michaelson Jennifer (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/22/2023 4:30 PM | Cullinan Therapeutics (Issuer) Trigilio Jeffrey (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/22/2023 4:30 PM | Cullinan Therapeutics (Issuer) SUMER JACQUELYN L (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/22/2023 4:30 PM | Cullinan Therapeutics (Issuer) Jones Jeffrey Alan (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/20/2023 5:00 PM | Cullinan Therapeutics (Issuer) Trigilio Jeffrey (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/20/2023 5:00 PM | Cullinan Therapeutics (Issuer) SUMER JACQUELYN L (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/20/2023 5:00 PM | Cullinan Therapeutics (Issuer) Michaelson Jennifer (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/20/2023 5:00 PM | Cullinan Therapeutics (Issuer) Jones Jeffrey Alan (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
Digitizing the $11T commodities sector with one tiny stock (Ad) One tiny company — trading completely undiscovered around 15-cents per share — has successfully partnered with some of the largest players in the industry to bring a first-of-its-kind digital solution to the global commodities supply chain sector. It’s an opportunity that likely won’t stay at these levels for long |
12/13/2023 7:00 PM | Cullinan Therapeutics (Issuer) Michaelson Jennifer (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/13/2023 7:00 PM | Cullinan Therapeutics (Issuer) Trigilio Jeffrey (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/08/2023 6:22 AM | Cullinan Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
11/08/2023 6:10 AM | Cullinan Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/07/2023 8:38 AM | BlackRock Inc. (Filed by) Cullinan Therapeutics (Subject)
| Form SC 13G/A | |
08/10/2023 6:44 AM | Cullinan Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
08/10/2023 6:07 AM | Cullinan Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/05/2023 8:27 PM | Cullinan Therapeutics (Issuer) Trigilio Jeffrey (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/29/2023 3:59 PM | AHMED NADIM (Reporting) Cullinan Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/21/2023 3:17 PM | Cullinan Therapeutics (Issuer) SUMER JACQUELYN L (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/21/2023 3:17 PM | Cullinan Therapeutics (Issuer) Trigilio Jeffrey (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/21/2023 3:17 PM | Cullinan Therapeutics (Issuer) Michaelson Jennifer (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/21/2023 3:17 PM | Cullinan Therapeutics (Issuer) Jones Jeffrey Alan (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/14/2023 3:35 PM | Cullinan Therapeutics (Issuer) Michaelson Jennifer (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/14/2023 3:35 PM | Cullinan Therapeutics (Issuer) Trigilio Jeffrey (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/14/2023 3:15 PM | Cullinan Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/12/2023 4:50 PM | Cullinan Therapeutics (Issuer) Martin Anne-Marie (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/12/2023 4:51 PM | Cullinan Therapeutics (Issuer) Webster Stephen W (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/12/2023 4:57 PM | Cullinan Therapeutics (Issuer) Rosenberg Anthony (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/12/2023 4:58 PM | Cullinan Therapeutics (Issuer) Ebeling Thomas (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |